NEULANDLAB - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 4.0
✅ Positive
The stock has shown significant growth recently, with a substantial quarterly profit variance of 666%. Furthermore, multiple analysts have issued positive ratings, including a 'Buy' rating and highlighting strong portfolio performance. Volume is also elevated compared to the weekly average, suggesting increased interest in the stock.
⚠️ Limitation
Despite impressive recent gains, the PEG ratio of 2.26 indicates that the stock’s price may be overvalued relative to its earnings growth. The high P/E ratio of 68.0 also suggests potential downside risk if growth slows.
📉 Company Negative News
None found
📈 Company Positive News
None found
🏭 Industry
Neuland Laboratories operates in the pharmaceutical ingredients sector, specifically focusing on custom manufacturing and contract research services for APIs (Active Pharmaceutical Ingredients). The industry is generally driven by generic drug demand and innovation, presenting opportunities for companies with specialized capabilities.
🧾 Conclusion
A potential entry point could be at 19,100 ₹, utilizing momentum from the recent high of 20,089 ₹. An initial profit-taking level would be set at 19,800 ₹, representing a 3% gain. A stop-loss order should be placed at 18,700 ₹ to mitigate potential losses if the upward momentum falters, considering the elevated P/E ratio and PEG ratio. Overall, given the strong recent performance and positive analyst sentiment, this stock presents a moderately attractive intraday trading opportunity.